Anzeige
Mehr »
Login
Dienstag, 03.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Eilmeldung: Goldshores aggressiver Winter-Explorationsplan nimmt Gestalt an
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
122 Leser
Artikel bewerten:
(0)

MAPS: Petition to Reinstate Medical Marijuana Researcher Receives Over 100,000 Signatures

Finanznachrichten News

PHOENIX, July 31, 2014 /PRNewswire-USNewswire/ -- A petition launched on Change.org by an Arizona veteran has gathered over 100,000 signatures in support of Dr. Sue Sisley's efforts to initiate medical marijuana research in Arizona. Launched on July 10, the petition reached 100,000 signatures in just 21 days.

The public outcry against Dr. Sisley's dismissal from the University of Arizona has reached a national audience. On June 27, the University of Arizona notified Dr. Sisley that her university appointments would be terminated as of September 26. On July 28, the University of Arizona expectedly denied Dr. Sisley's appeal for reinstatement, forcing Dr. Sisley to seek a new location for the study.

Arizona veteran Ricardo Pereyda, who launched the petition, writes: "The Arizona Board of Regents must reinstate Dr. Sisley at one of our other public universities, providing her with the necessary space and resources she needs to conduct her research. Her study could mean life or death for many veterans. 'Bigger Questions, Better Answers' is the motto The University of Arizona has failed to live up to-let's see if Northern Arizona University or Arizona State University will take up the challenge."

The petition originally called for Dr. Sisley's reappointment at the University of Arizona. Following the rejection of her appeal, Pereyda updated the petition to encourage the Arizona Board of Regents help her find a new home for the study at another Arizona university.

Dr. Sisley has been working with the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) since 2010 to initiate a study of the safety and effectiveness of whole plant marijuana for symptoms of posttraumatic stress disorder (PTSD) in 70 U.S. veterans. The study has approval from the U.S. Food and Drug Administration and the University of Arizona Institutional Review Board. In March 2014, the study became the first whole plant medical marijuana drug development research to receive approval from the U.S. Department of Health and Human Services to purchase marijuana from the National Institute on Drug Abuse (NIDA), which maintains a monopoly on marijuana for research in the U.S. NIDA has reported that it will not be able to provide the marijuana needed for the study until about January 2015.

With reinstatement at the University of Arizona no longer a possibility, MAPS and Dr. Sisley are seeking a new location for the study within Arizona. Multiple universities outside Arizona have already offered to host the study.

The University of Arizona has stated that it views the study as important and proposed a new Principal Investigator. "We appreciate that UA has taken a public position in favor of this research taking place at UA, but MAPS will not fire Dr. Sisley as the Principal Investigator," says MAPS founder and executive director Rick Doblin, Ph.D. "Instead, we appeal to the Arizona Board of Regents to permit Dr. Sisley to move herself and the study to another Arizona state university."

On July 22, Dr. Andrew Weil, founder of the Arizona Center for Integrative Medicine at the University of Arizona, wrote a letter to University of Arizona President Dr. Ann Weaver Hart expressing his support for Dr. Sisley's work. "Dr. Sisley has passionately chosen her professional obligation to patients over political pressure; she has chosen science over dogma; and has chosen integrity over censorship. This is the type of individual any University should want on their faculty."

"This research is long overdue and veterans are dying every day who may be able to benefit from it," says Drug Policy Alliance Policy Coordinator Jessica Gelay. "By finding a home for MAPS and Dr. Sisley's research in Arizona, the Arizona Board of Regents now has a chance to help find out whether marijuana can help save the lives of veterans."

SOURCE Multidisciplinary Association for Psychedelic Studies (MAPS)

© 2014 PR Newswire
Treibt Nvidias KI-Boom den Uranpreis?
In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.